GL1X · GenesisL1 explorer

Research workbench

Crystal structure of sting complex with cyclic di-gmp.

Analyse Crystal structure of sting complex with cyclic di-gmp. in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4F9G
Type
protein
Length
339 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transmembrane protein 173
UniProt
Q86WV6
Ligands
C2E
Pockets
5 · best druggability 0.54

Structure

x-ray diffraction · 2 distinct chains · 51% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATransmembrane protein 173protein17051% helix, 22% strandQ86WV6
CTransmembrane protein 173protein16951% helix, 22% strandQ86WV6

Ligands and binding sites

  • C2E · 9,9'-[(2r,3r,3as,5s,7ar,9r,10r,10as,12s,14ar)-3,5,10, 12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3, 2-D:3',2'-J][1,3,7,9,2, 8]tetraoxadiphosphacyclododecine-2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin-6-one) · ligand · chains A, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13640.540.7442C2E
2810.320.7416empty
3650.300.7415empty
4620.290.7414empty
5650.290.7313empty

Interfaces

1 interface between chains.

  • A–C · 855 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 4F9G · Crystal structure of STING complex with Cyclic di-GMP. · the same entry in another collection · chain A against A, TM-score 1.00
  • Q86WV6 · AlphaFold monomer V2.0 prediction for stimulator of interferon genes protein (Q86WV6) · a predicted model of the same protein · chain C against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.